Aldeyra receives FDA rejection for dry eye drug reproxalap
Go back to Aldeyra receives FDA rejection for dry eye drug reproxalap| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 2.30 +0.17 (7.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.13 | 52 Week High | $8.19 | |||
| Open | $2.14 | 52 Week Low | $3.39 | |||
| Day High | $2.31 | P/E | N/A | |||
| Day Low | $2.06 | EPS | $0.00 | |||
| Volume | 2,084,735 | |||||
